依那普利成功治疗严重充血性心力衰竭
Successful management of severe congestive cardiac failure with enalapril.
作者信息
Dickstein K, Gundersen T
出版信息
Am J Med. 1983 Oct;75(4):721-3. doi: 10.1016/0002-9343(83)90464-3.
PMID:6312795
Abstract
The new angiotensin-converting enzyme inhibitor enalapril (MK-421) was administered to a patient with severe congestive cardiac failure. Dramatic and sustained symptomatic and hemodynamic improvement is reported. The possible clinical significance of this agent's favorable profile is briefly discussed.
摘要
新型血管紧张素转换酶抑制剂依那普利（MK - 421）被用于治疗一名严重充血性心力衰竭患者。据报道，该患者症状和血流动力学得到显著且持续的改善。本文简要讨论了该药物良好特性可能具有的临床意义。
Zotero 插件